Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry | Journal of Proteome Research
Reference ranges of the Sebia free light chain ratio in patients with chronic kidney disease
Criteria for Presumptive Diagnosis of IgD Multiple Myeloma
FLC Why choose the Sebia Free Light Chain (FLC) assay?
A universal reference interval for serum immunoglobulins free light chains may be outdated
Evaluation of the new Sebia free light chain assay using the AP22 ELITE instrument - ScienceDirect
Table 3 from Prevalence and clinical significance of abnormal serum kappa/ lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Comparison of Sebia FLC with N Latex FLC and Freelite in the... | Download Scientific Diagram
Is this a true lambda free light chain?
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
Detection of oligoclonal IgG kappa and IgG lambda bands in cerebrospinal fluid and serum with Hevylite™ antibodies. comparison with the free light chain oligoclonal pattern | Fluids and Barriers of the CNS
Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal
Hani Rustom posted on LinkedIn
Human Kappa and Lambda Free Light Chain Control - Sekisui Diagnostics
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Kappa/lambda serum FLC ratio in patients with IgG4-RD. Comparison of... | Download Scientific Diagram
Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal
Evaluation of the new Sebia free light chain assay using the AP22 ELITE instrument - ScienceDirect
Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma | Blood Cancer Journal